In 2023, the seven peptides being discussedBPC-157, KPV, TB-500, MOTS-C, emideltide, Epitalon, and Semaxwere among more than a dozen that the FDA essentially banned compounding pharmacies from dispensing, saying that they may present significant safety risks. Compounding pharmacies are specialty pharmacies that produce drugs with a doctors prescription
Ultimately, whether or not BPC-157 is worth the risk depends on your personal goalsand your tolerance for regulatory ambiguity
Catalytic role of the alpha-carboxylate of the Glu residue of glutathione in glutathione S-transferases
Storage and Handling : Proper storage conditions affect peptide stability and may influence the development of degradation products that could cause adverse reactions
Strbe S et al
Meanwhile, BPC-157 stimulates VEGF locally, encouraging blood vessel formation right where it is needed most